- Details
- Description
Packaging Size:
60t/bottle
Strength:
10mg
Composition:
Olverembatinib
Form:
tablet
Brand:
耐立克
Quantity Unit:
10mg*60t/box
Manufacturer:
Ascentage Pharma.,China
Olverembatinib is a small-molecule, oral BCR-ABL1 TKI that works by inhibiting the BCR-ABL1 kinase at the ATP binding site. It's designed to be effective against both wild-type and mutant BCR-ABL1.
- Olverembatinib sold under the brand name 耐立克® in china.
In 2021, it was approved in China "for the treatment of adult patients with TKI-resistant chronic-phase CML (CML-CP) or accelerated-phase CML (CML-AP) harbouring the T315I mutation"
